PARTNER NEWS:Mon, Apr 15, 10:00 AM, Zacks
All You Need to Know About Werewolf Therapeutics (HOWL) Rating Upgrade to Buy Werewolf Therapeutics (HOWL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Tue, Mar 12, 7:55 AM, Zacks
How Much Upside is Left in Werewolf Therapeutics, Inc. (HOWL)? Wall Street Analysts Think 92.37% The consensus price target hints at a 92.4% upside potential for Werewolf Therapeutics, Inc. (HOWL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Featured MNV Articles: AFLAC Named Top Dividend Stock With Insider Buying and 2.33% Yield (AFL)
Tuesday, May 14, 5:27 PM ET, by Market News Video Staff
In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then ...
Adecoagro Breaks Below 200-Day Moving Average - Notable for AGRO
Tuesday, May 14, 5:26 PM ET, by Market News Video Staff
In trading on Tuesday, shares of Adecoagro SA (AGRO) crossed below their 200 day moving ...
Oversold Conditions For Ulta Beauty
Tuesday, May 14, 5:25 PM ET, by Market News Video Staff
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
Ascendis Pharma is Now Oversold (ASND)
Tuesday, May 14, 5:25 PM ET, by Market News Video Staff
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
Krispy Kreme Becomes Oversold (DNUT)
Tuesday, May 14, 5:25 PM ET, by Market News Video Staff
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
|
|
By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
|